Annual Operating Expenses:
$604.83M+$177.39M(+41.50%)Summary
- As of today, AXSM annual total operating expenses is $604.83 million, with the most recent change of +$177.39 million (+41.50%) on December 31, 2024.
- During the last 3 years, AXSM annual operating expenses has risen by +$480.12 million (+385.00%).
- AXSM annual operating expenses is now at all-time high.
Performance
AXSM Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Expenses:
$189.59M+$10.31M(+5.75%)Summary
- As of today, AXSM quarterly total operating expenses is $189.59 million, with the most recent change of +$10.31 million (+5.75%) on September 30, 2025.
- Over the past year, AXSM quarterly operating expenses has increased by +$49.10 million (+34.94%).
- AXSM quarterly operating expenses is now at all-time high.
Performance
AXSM Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
AXSM Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +41.5% | +34.9% |
| 3Y3 Years | +385.0% | +242.2% |
| 5Y5 Years | +801.3% | +797.6% |
AXSM Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +385.0% | at high | +242.2% |
| 5Y | 5-Year | at high | +801.3% | at high | +797.6% |
| All-Time | All-Time | at high | >+9999.0% | at high | >+9999.0% |
AXSM Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $189.59M(+5.8%) |
| Jun 2025 | - | $179.28M(+8.6%) |
| Mar 2025 | - | $165.01M(-1.7%) |
| Dec 2024 | $604.83M(+41.5%) | $167.81M(+19.4%) |
| Sep 2024 | - | $140.50M(-8.3%) |
| Jun 2024 | - | $153.14M(+13.0%) |
| Mar 2024 | - | $135.56M(+15.4%) |
| Dec 2023 | $427.44M(+93.1%) | $117.48M(+5.4%) |
| Sep 2023 | - | $111.48M(+12.6%) |
| Jun 2023 | - | $98.96M(+8.1%) |
| Mar 2023 | - | $91.58M(+20.8%) |
| Dec 2022 | $221.34M(+77.5%) | $75.78M(+36.8%) |
| Sep 2022 | - | $55.41M(+18.9%) |
| Jun 2022 | - | $46.61M(+22.7%) |
| Mar 2022 | - | $37.98M(+17.6%) |
| Dec 2021 | $124.71M(+25.9%) | $32.30M(-2.4%) |
| Sep 2021 | - | $33.11M(+8.3%) |
| Jun 2021 | - | $30.57M(+9.8%) |
| Mar 2021 | - | $27.84M(+0.4%) |
| Dec 2020 | $99.09M(+47.7%) | $27.74M(+31.3%) |
| Sep 2020 | - | $21.12M(+18.8%) |
| Jun 2020 | - | $17.77M(-45.3%) |
| Mar 2020 | - | $32.49M(+33.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $67.11M(+105.7%) | $24.42M(+29.0%) |
| Sep 2019 | - | $18.94M(+40.9%) |
| Jun 2019 | - | $13.44M(+29.1%) |
| Mar 2019 | - | $10.41M(+10.3%) |
| Dec 2018 | $32.63M(+21.0%) | $9.44M(+14.7%) |
| Sep 2018 | - | $8.23M(+3.2%) |
| Jun 2018 | - | $7.98M(+11.6%) |
| Mar 2018 | - | $7.15M(+11.2%) |
| Dec 2017 | $26.96M(-0.4%) | $6.43M(+2.3%) |
| Sep 2017 | - | $6.29M(-6.7%) |
| Jun 2017 | - | $6.74M(-12.0%) |
| Mar 2017 | - | $7.66M(+0.6%) |
| Dec 2016 | $27.07M(+194.3%) | $7.62M(+5.7%) |
| Sep 2016 | - | $7.20M(+5.5%) |
| Jun 2016 | - | $6.82M(+16.0%) |
| Mar 2016 | - | $5.88M(+86.4%) |
| Dec 2015 | $9.20M(+67.6%) | $3.15M(+55.9%) |
| Sep 2015 | - | $2.02M(-2.9%) |
| Jun 2015 | - | $2.08M(+7.8%) |
| Mar 2015 | - | $1.93M(-0.8%) |
| Dec 2014 | $5.49M(+198.4%) | $1.95M(+14.8%) |
| Sep 2014 | - | $1.70M |
| Dec 2013 | $1.84M | - |
FAQ
- What is Axsome Therapeutics, Inc. annual total operating expenses?
- What is the all-time high annual operating expenses for Axsome Therapeutics, Inc.?
- What is Axsome Therapeutics, Inc. annual operating expenses year-on-year change?
- What is Axsome Therapeutics, Inc. quarterly total operating expenses?
- What is the all-time high quarterly operating expenses for Axsome Therapeutics, Inc.?
- What is Axsome Therapeutics, Inc. quarterly operating expenses year-on-year change?
What is Axsome Therapeutics, Inc. annual total operating expenses?
The current annual operating expenses of AXSM is $604.83M
What is the all-time high annual operating expenses for Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. all-time high annual total operating expenses is $604.83M
What is Axsome Therapeutics, Inc. annual operating expenses year-on-year change?
Over the past year, AXSM annual total operating expenses has changed by +$177.39M (+41.50%)
What is Axsome Therapeutics, Inc. quarterly total operating expenses?
The current quarterly operating expenses of AXSM is $189.59M
What is the all-time high quarterly operating expenses for Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. all-time high quarterly total operating expenses is $189.59M
What is Axsome Therapeutics, Inc. quarterly operating expenses year-on-year change?
Over the past year, AXSM quarterly total operating expenses has changed by +$49.10M (+34.94%)